Table of Content

Open Access iconOpen Access

ORIGINAL ARTICLE

IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features

Maryam Zarrabi1, Nasser Gholijani1, Saeedeh Shenavandeh2, Elham Aflaki2, Zahra Amirghofran1,3

1 Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Division of Rheumatology, Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
3 Immunology Department, Shiraz University of Medical Sciences, Shiraz, Iran

* Corresponding Authors: Zahra Amirghofran, email, email

European Cytokine Network 2019, 30(3), 82-87. https://doi.org/10.1684/ecn.2019.0430

Abstract

Behcet’s disease (BD) is a chronic multisystem autoimmune disorder. Various cytokines take part in the pathogenesis of this disease. Interleukin (IL)-38, a new member of IL-1 cytokine family, has been reported to have antiinflammatory properties; however, its role in BD has not been investigated yet. In this study, we aimed to examine the probable role of IL-38 in the clinical context of BD. A total of 81 patients with BD and 81 age- and sex-matched healthy subjects as controls were included in this study. The serum levels of IL-38 were measured in patients and controls sera using enzyme-linked immunosorbent assay. The relationship between the serum levels of IL-38 and clinical and laboratory characteristics of the patients were determined. IL-38 serum levels were significantly lower in patients in comparison with healthy controls at P = 0.003. We found significant differences between IL-38 levels in BD patients with positive and negative pathergy tests (P = 0.048) and patients with and without eye involvement (P = 0.046). Despite the absence of significant differences in serum levels between male and female patients, IL-38 levels were higher in female patients with a positive pathergy test (P = 0.048) and those patients with eye involvement (P = 0.046). As healthy controls showed higher IL-38 serum levels than patients, a protective anti-inflammatory role of IL-38 in BD is suggested. Together, these results suggest that the positive relationship between IL-38 serum levels and eye involvement that IL-38 may play a role in this clinical feature of the disease.

Keywords

IL-38, Behcet’s disease, autoimmune disease, cytokine

Cite This Article

APA Style
Zarrabi, M., Gholijani, N., Shenavandeh, S., Aflaki, E., Amirghofran, Z. (2019). IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features. European Cytokine Network, 30(3), 82–87. https://doi.org/10.1684/ecn.2019.0430
Vancouver Style
Zarrabi M, Gholijani N, Shenavandeh S, Aflaki E, Amirghofran Z. IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features. Eur Cytokine Network. 2019;30(3):82–87. https://doi.org/10.1684/ecn.2019.0430
IEEE Style
M. Zarrabi, N. Gholijani, S. Shenavandeh, E. Aflaki, and Z. Amirghofran, “IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features,” Eur. Cytokine Network, vol. 30, no. 3, pp. 82–87, 2019. https://doi.org/10.1684/ecn.2019.0430



cc Copyright © 2019 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 76

    View

  • 75

    Download

  • 0

    Like

Share Link